Younossi Z - Search Results

1

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Poynard T, et al. Among authors: younossi z. Hepatology. 2003 Jul;38(1):75-85. doi: 10.1053/jhep.2003.50267. Hepatology. 2003. PMID: 12829989 Clinical Trial.

2

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.

Pockros PJ, Shiffman ML, Schiff ER, Sulkowski MS, Younossi Z, Dieterich DT, Wright TL, Mody SH, Tang KL, Goon BL, Bowers PJ, Leitz G, Afdhal NH; PROACTIVE Study Group. Pockros PJ, et al. Among authors: younossi z. Hepatology. 2004 Dec;40(6):1450-8. doi: 10.1002/hep.20482. Hepatology. 2004. PMID: 15565613 Clinical Trial.

3

Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.

Younossi ZM, McCullough AC, Barnes DS, Post A, Ong JP, O'Shea R, Martin LM, Bringman D, Farmer D, Levinthal G, Mullen KD, Carey WD, Tavill AS, Ferguson R, Gramlich T. Younossi ZM, et al. Dig Dis Sci. 2005 May;50(5):970-5. doi: 10.1007/s10620-005-2673-y. Dig Dis Sci. 2005. PMID: 15906777 Clinical Trial.

4

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. Younossi ZM, et al. Hepatology. 2005 Sep;42(3):665-74. doi: 10.1002/hep.20838. Hepatology. 2005. PMID: 16116632

5

Depression, anemia and health-related quality of life in chronic hepatitis C.

Dan AA, Martin LM, Crone C, Ong JP, Farmer DW, Wise T, Robbins SC, Younossi ZM. Dan AA, et al. J Hepatol. 2006 Mar;44(3):491-8. doi: 10.1016/j.jhep.2005.11.046. Epub 2005 Dec 27. J Hepatol. 2006. PMID: 16427157

6

The effects of HCV infection and management on health-related quality of life.

Younossi Z, Kallman J, Kincaid J. Younossi Z, et al. Hepatology. 2007 Mar;45(3):806-16. doi: 10.1002/hep.21565. Hepatology. 2007. PMID: 17326207 Review.

7

Pathologic assessment of non-alcoholic fatty liver disease.

Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM. Bondini S, et al. Clin Liver Dis. 2007 Feb;11(1):17-23, vii. doi: 10.1016/j.cld.2007.02.002. Clin Liver Dis. 2007. PMID: 17544969 Review.

8

A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.

Calvert VS, Collantes R, Elariny H, Afendy A, Baranova A, Mendoza M, Goodman Z, Liotta LA, Petricoin EF, Younossi ZM. Calvert VS, et al. Among authors: younossi zm. Hepatology. 2007 Jul;46(1):166-72. doi: 10.1002/hep.21688. Hepatology. 2007. PMID: 17596878

9

Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.

Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, Afendy M, Fang Y, Elariny H, Goodman Z, Younossi ZM. Mishra P, et al. Among authors: younossi zm. Liver Int. 2008 Sep;28(8):1080-6. doi: 10.1111/j.1478-3231.2008.01822.x. Epub 2008 Jul 18. Liver Int. 2008. PMID: 18647236

10

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.

Younossi ZM, Baranova A, Afendy A, Collantes R, Stepanova M, Manyam G, Bakshi A, Sigua CL, Chan JP, Iverson AA, Santini CD, Chang SY. Younossi ZM, et al. Hepatology. 2009 Mar;49(3):763-74. doi: 10.1002/hep.22729. Hepatology. 2009. PMID: 19140155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters